Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center (UM2 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) invites applications to participate in a research program cooperative agreement to support the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN). The Network will have the capacity to develop and conduct innovative behavioral, community-based, translational, therapeutic, microbicide and vaccine trials in youth ages 13-24 years at-risk for HIV and living with HIV, with a focus on the inclusion of minors. Investigators with innovative approaches to address the public health issues facing adolescents are encouraged to apply.

Companion FOA:  RFA-HD-23-021 , UM2 Program Project or Center with Complex Structure Cooperative Agreement


  • Letter of Intent Due Date(s): 30 days before the application due date

  • AIDS Application Due Date:  March 31, 2022

RFA-HD-23-020 Expiration Date April 01, 2022

Agency Website

Amount Description

Budgets up to $6.875M direct costs per year may be requested.

Project period is 7 years.

Funding Type





Community Outreach and Engagement
Medical - Clinical Science
Medical - Translational
Social Sciences

External Deadline

March 31, 2022